Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06615661 · ClinicalTrials.gov registry record
A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma
A clinical trial of Primary Open Angle Glaucoma (POAG), sponsored by Iantrek.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT06615661: Recruiting study of Primary Open Angle Glaucoma (POAG), sponsored by Iantrek.
NCT06615661 is a study of Primary Open Angle Glaucoma (POAG) that is actively recruiting participants, run by Iantrek. The registered enrollment target is 200 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06615661, a study of Primary Open Angle Glaucoma (POAG), is actively recruiting participants, sponsored by Iantrek.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.
Primary Outcome
Intraocular pressure (IOP) is at least 20% lower than before surgery without additional ocular hypotensive medications or IOP-lowering surgery.
Conditions Studied
Interventions
- DEVICE C-Rex Instrument
Study Locations (2)
Georgia
- Omni Eye Services - Atlanta
Tennessee
- CIRCLE Site 04 - Crossville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2026-10 |
What NCT06615661 shows while recruiting
NCT06615661 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Primary Open Angle Glaucoma (POAG) appearing as the primary indexed condition, and to 1 intervention - of which C-Rex Instrument is the first listed.
NCT06615661 reports a single indexed study location in Georgia, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06615661 about?
NCT06615661 is a clinical study titled "A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma". This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and an...
What is the current status of trial NCT06615661?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-14. Estimated completion is 2026-10.
What conditions does trial NCT06615661 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma (POAG).
What interventions are being tested in trial NCT06615661?
The interventions under investigation include: C-Rex Instrument (DEVICE).
Who is sponsoring clinical trial NCT06615661?
This trial is sponsored by Iantrek, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06615661 being conducted?
This trial has 2 study locations across Georgia, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma (POAG)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI